Healthcare -
Biotechnology - NASDAQ - US
$ 2.785
12.9 %
$ 243 M
Market Cap
-2.42
P/E
TERN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TERN - Terns Pharmaceuticals, Inc.
164 M
LAST VALUE
-1.05%
2 YEAR CAGR
383.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR